Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Aggarwal C, Saba NF, Algazi A, Sukari A, Seiwert TY, Haigentz M, Porosnicu M, Bonomi M, Boyer J, Esser MT, Cheng LI, Agrawal S, Jennings EC, Durham NM, Fraser K, Lissa D, Gong M, Ceaicovscaia N, Gascó Hernández A, Kumar R. Aggarwal C, et al. Among authors: gong m. Clin Cancer Res. 2023 Feb 1;29(3):560-570. doi: 10.1158/1078-0432.CCR-22-1987. Clin Cancer Res. 2023. PMID: 36455147 Free PMC article.
MEDI0457 Plus Durvalumab in HPV-associated HNSCC-Response.
Aggarwal C, Gong M, Kumar R. Aggarwal C, et al. Among authors: gong m. Clin Cancer Res. 2023 Jul 14;29(14):2736. doi: 10.1158/1078-0432.CCR-23-1057. Clin Cancer Res. 2023. PMID: 37449358 No abstract available.
Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors.
Davar D, Carneiro BA, Dy GK, Sheth S, Borad MJ, Harrington KJ, Patel SP, Galanis E, Samson A, Agrawal S, Chen Z, Fan C, Gong M, Burton J, Tu E, Durham N, Laubscher K, Arnaldez F, Zamarin D. Davar D, et al. Among authors: gong m. J Immunother Cancer. 2024 Nov 17;12(11):e009336. doi: 10.1136/jitc-2024-009336. J Immunother Cancer. 2024. PMID: 39551600 Free PMC article. Clinical Trial.
Effects of patent foramen ovale in migraine: a metabolomics-based study.
Dong B, Li X, Zhang L, Liang G, Zheng W, Gui L, Ji S, Tang Y, Li H, Li W, Yang R, Li Y, Peng A, Chen Y, Gong M, Chen L. Dong B, et al. Among authors: gong m. J Physiol. 2025 Jan 21. doi: 10.1113/JP286772. Online ahead of print. J Physiol. 2025. PMID: 39838589
3,280 results